Search

everythinglearnresearchcommunity

for

Search:↓

Changing the C-ring structure in certain compounds can make them better at blocking a specific human enzyme.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

The enzyme 5α-reductase is important for proper blood vessel development during the fertility-related transformation of the uterus lining.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

Young girls whose mothers have PCOS may have higher activity of a specific enzyme that could lead to developing PCOS later.

The enzyme 5α-reductase type 1 is important for blood vessel development and fertility in the uterus.

Low testosterone does not prevent prostate cancer in men with type 1 diabetes.

Three compounds were found to inhibit a prostate disease-related enzyme and reduce prostate size more effectively than the current treatment, suggesting they could be used for treating benign prostatic hyperplasia.

Minoxidil and finasteride can slow hair loss and stimulate regrowth, but won't restore all lost hair or reverse complete baldness.

Personalized treatment with inhibitors, minoxidil, and laser therapy helps hair loss.

FCE 28260 is a stronger and longer-lasting inhibitor of 5α-reductase than finasteride, which may make it a better treatment for certain medical conditions.

Finasteride effectively treats enlarged prostate and male baldness, improves symptoms of hirsutism in women, but doesn't work for acne, and may delay prostate cancer progression with few side effects.

5α-reductase inhibitors, like finasteride and dutasteride, effectively treat BPH, male baldness, and hirsutism, with potential for acne and prostate cancer prevention.

Saw palmetto extract can block the enzyme that converts testosterone in pig prostate cells.

Four new compounds were more effective than finasteride in treating prostate issues and hair loss, with one being 100 times more active and safe for use.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Finasteride lowers PSA levels about the same whether taken at 1 mg or 5 mg daily.

Testosterone increases 3α-androstanediol levels, which can be blocked by finasteride.

Men taking dutasteride or finasteride have a slightly higher risk of developing type 2 diabetes.

Allopregnanolone is needed for certain brain processing issues caused by D1 dopamine receptor activation.

5α-reductase is essential for male sexual development and its inhibitors have potential in treating various conditions related to hormone action.

Dihydrotestosterone treatment can help penis growth in boys with 5α-reductase deficiency but doesn't fully normalize size after puberty.

The human type II 5α-reductase gene, linked to certain male health conditions, has a specific structure and low similarity to other related genes.

The human type II 5α-reductase gene has a specific structure important for understanding certain medical conditions.

Testosterone's muscle-building effects do not require its conversion to DHT.

Male yak hair growth is influenced by DHT synthesis, which is promoted by 5α-red1 and AR during growth phases, while E2 may inhibit growth through ERα.

Dicentrine reduced heart disease risk factors in rats, T-588 protected mice brains without side effects, Provir blocked herpes virus and lessened mouse symptoms, and LY191704 could treat hair loss and prostate issues.

New treatments for enlarged prostate are being developed to be more effective and have fewer side effects.

Men with early balding showed higher levels of certain genes linked to hair loss and possibly prostate cancer.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.